The present study analyzed history of smoking and willingness to quit smoking in patients referred for diagnosis and treatment of different oral mucosal lesions. Prior to the initial clinical examination, patients filled in a standardized questionnaire regarding their current and former smoking habits and willingness to quit. Definitive diagnoses were classified into three groups (benign/reactive lesions, premalignant lesions and conditions, and malignant diseases) and correlated with the self-reported data in the questionnaires. Of the 980 patients included, 514 (52%) described themselves as never smokers, 202 (21%) as former smokers, and 264 (27%) as current smokers. In the group of current smokers, 23% thought their premalignant lesions/conditions were related to their smoking habit, but only 15% of the patients with malignant mucosal diseases saw that correlation. Only 14% of the smokers wanted to commence smoking cessation within the next 30 days. Patients with malignant diseases (31%) showed greater willingness to quit than patients diagnosed with benign/reactive lesions (11%). Future clinical studies should attempt (1) to enhance patients' awareness of the negative impact of smoking on the oral mucosa and (2) to increase willingness to quit in smokers referred to a dental/oral medicine setting.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00784-010-0488-5 | DOI Listing |
Cureus
November 2024
Department of Public Health Sciences, Penn State University College of Medicine, Milton S. Hershey Medical Center, Hershey, USA.
Background The effects of tobacco use create a significant burden on the American healthcare system. The U.S.
View Article and Find Full Text PDFBMC Public Health
December 2024
Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Centre Hamburg- Eppendorf, Martinistrasse 52, Hamburg, 20246, Germany.
Background: Tobacco smoking is a relevant determinant of multiple sclerosis (MS) onset, and smokers have increased risk for faster progression of MS compared to non-smokers. While the smoking prevalence is high in Germany, no smoking cessation programs have been developed specifically in MS populations to date, and only little is known about the motivators and barriers influencing smoking cessation in people with MS (pwMS) in Germany. This study aims to identify these factors to inform the design of a tailored smoking cessation intervention.
View Article and Find Full Text PDFJ Neurosci
November 2024
Department of Psychological and Brain Sciences, Boston University, Boston, MA 02215.
Deciding how long to keep waiting for uncertain future rewards is a complex problem. Previous research has shown that choosing to stop waiting results from an evaluative process that weighs the subjective value of the awaited reward against the opportunity cost of waiting. Activity in ventromedial prefrontal cortex (vmPFC) tracks the dynamics of this evaluation, while activation in the dorsomedial prefrontal cortex (dmPFC) and anterior insula (AI) ramps up before a decision to quit is made.
View Article and Find Full Text PDFClin Genitourin Cancer
October 2024
Department of Urology, University of North Carolina at Chapel Hill, NC; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC. Electronic address:
Purpose: Despite a 3-fold increase in risks of bladder cancer (BC) among current smokers, smoking cessation therapy for patients undergoing treatment is significantly underutilized. Inpatient admission after surgery provides a teachable moment to pursue tobacco treatment. We conducted a 12-month prospective quality improvement initiative to increase tobacco treatment program (TTP) consultations with BC patients who smoke and underwent radical cystectomy (RC).
View Article and Find Full Text PDFS Afr Fam Pract (2004)
October 2024
Department of Family Medicine and Primary Care, Faculty of Health Sciences, School of Medicine, University of the Witwatersrand, Johannesburg.
Background: Despite its hampering influence on the willingness of healthcare professionals (HCPs) to implement tobacco cessation treatments, the tobacco use status of these professionals remains understudied in South Africa.
Methods: This cross-sectional study, which sampled 444 HCPs, was conducted in five community health centres in Soweto. A self-administered questionnaire collected information on socio-demography, tobacco use, quit attempts and readiness to implement tobacco cessation treatments for their patients.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!